ISSN: 1935-1232

Journal Home

Journal Guideline

Clinical Schizophrenia and Related Psychoses Q4 Unclaimed

Walsh Medical Media, LLC United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Schizophrenia and Related Psychoses is a journal indexed in SJR in Medicine (miscellaneous) and Psychiatry and Mental Health with an H index of 27. It has an SJR impact factor of 0,114 and it has a best quartile of Q4. It has an SJR impact factor of 0,114.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q4) Psychiatry and Mental Health (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Clinical Schizophrenia and Related Psychoses

0,114

SJR Impact factor

27

H Index

21

Total Docs (Last Year)

115

Total Docs (3 years)

510

Total Refs

57

Total Cites (3 years)

107

Citable Docs (3 years)

0.44

Cites/Doc (2 years)

24.29

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

North Carolina Medical Journal Q4
European Journal of Mass Spectrometry Q4
Israel Medical Association Journal Q4
Neuroendocrinology Letters Q4
Medico-Legal Journal Q4

Compare this journals

Aims and Scope

Best articles by citations

Psychosis Following the Addition of Pramipexole in an Intellectually Disabled Adult

Successful Electroconvulsive Therapy in a Clozapine-Refractory Schizophrenia Patient with Meningioma

Implementing Treatment Guidelines

Toward a Meta-Analytic Approach of Sex Differences in Episodic Memory of Schizophrenia Patients: Exploratory Findings

Do the Causal Paths to Psychosis Converge on D2High?

Promoting Therapeutic Alliance in Clozapine Users: An Exploratory Randomized Controlled Trial

Poor Premorbid Adjustment and Dysfunctional Executive Abilities Predict Theory of Mind Deficits in Stabilized Schizophrenic Outpatients

A Pilot Study to Determine a Prolactin Threshold that Identifies Improved Sexual Functioning when Switching from a Prolactin-Elevating to a Prolactin-Neutral Antipsychotic

Assessing Intimidation Using a Brief Intrusiveness Measure

Cognitive Profile During Remission: Euthymic Bipolar Disorder Patients Compared to Schizophrenia Patients

Letters to the Editor

Can Transcranial Direct Current Stimulation Improve Cognitive Functioning in Adults with Schizophrenia?

SHOW MORE ARTICLES

Schizophrenia: 1979-2009

The Importance of Screening for Osteoporosis in Mental Health Settings

Why Not Clozapine?

Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial

New Serotonin/Dopamine Antagonists for the Treatment of Schizophrenia

The Effects of Olanzapine and Risperidone on Learning and Retaining Entry-Level Work Skills

The Neuroanatomy of Verbal Working Memory in Schizophrenia: A Voxel-Based Morphometry Study

Combination of Estrogen and Antipsychotics in the Treatment of Women with Chronic Schizophrenia

Weight Loss Interventions for Patients with Schizophrenia

Correlates of Suicide-Related Ideations and Attempts in Patients with Acute and Transient Psychotic Disorder

Factors Associated with Dropout and Noncompliance in Patients with Schizophrenia: Results of a One-Year Follow-Up

Exacerbation of Psychosis: A Case of Possible Varenicline-Mediated Effects in an Intellectually Disabled Adult